The episode discusses the challenges and cultural implications surrounding the development of Addyi, the first FDA-approved medication for women's low libido, featuring insights from industry experts.
In today’s episode of Bite Back with Abbey Sharp, we explore the politics, science, and cultural debate surrounding women’s sexual desire and the development of the first FDA-approved medication for low libido. Joined by Julie Bristow, executive producer of the documentary The Pink Pill: Sex, Drugs, and Who Has Control, and Cindy Eckert, founder of Sprout Pharmaceuticals, we unpack the long road to bringing Addyi to market and what the fight for a “female Viagra” reveals about gender bias in medicine, sexual autonomy, and whose health needs are prioritized.
People in this episode
Host: Abbey Sharp
Guests: Cindy Eckert, Julie Bristow
Topics covered
women's sexual desire
FDA-approved medication
gender bias in medicine
sexual autonomy
health needs
cultural debate
Keywords
women's health
sexual desire
Addyi
Viagra
gender bias
FDA
Cindy Eckert
Julie Bristow
Mentioned in this episode
Organizations: Sprout Pharmaceuticals
Products: Addyi, Viagra
Books & works: The Pink Pill: Sex, Drugs, and Who Has Control